SCHEMBL5453802

SCHEMBL5453802

CCCCCCCCCCCC(CCCCCC)Oc1ccccc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.58
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
RECQL P46063 1/20 0.58
ALDH1A1 P00352 5/20 0.57
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 2/20 0.48
NR1I2 O75469 1/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
MAPT P10636 1/20 0.48
OPRK1 P41145 1/20 0.48
HTR2B P41595 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HSD17B10 Q99714 3/20 0.46
HPGD P15428 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15263303 1.00 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL2374608 1.00 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL3185045 1.00 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL10458043 1.00 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL368882 0.99 KDM4E (0.57) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL2523396 0.99 KDM4E (0.57) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL2526219 0.99 KDM4E (0.57) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL29609629 0.97 KDM4E (0.56) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL2522070 0.97 KDM4E (0.56) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL9324896 0.94 KDM4E (0.56) KDM4EKMT2AMEN1RECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070092462-A1 Cosmetic compositions CITICORP USA, INC. 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070092462-A1 Cosmetic compositions PLOD3, COL14A1, COL2A1 KDM4E 3236/4885KMT2A 4010/4885MEN1 879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.